Project Partner
Our international group of experts
Joint Programming Initiative on Antimicrobial Resistance
| Name | Affiliation | Country | Nature of contribution | |
|---|---|---|---|---|
| Till T. Bachmann | University of Edinburgh UK | UK | Coordinator, Diagnostic (Dx) Innovator | |
| Alex van Belkum | Biomerieux | FR | Dx Industry | |
| A MacGowan | North Bristol NHS Trust | UK | Health, Policy | |
| Aman Russom | KTH Royal Institute of Technology | SE | Dx Innovator | |
| Andrew Shepherd | Omega Diagnostics | UK | Dx Industry | |
| Ann Van den Bruel | NIHR Diagnostic Evidence Cooperative | UK | Dx Implementation, Health | |
| Annika Eriksson | HemoCue AB | SE | Dx Industry | |
| Barbara Fallowfield | British In Vitro Diagnostics Association | UK | Dx Industry Association | |
| Bill Rodriguez | Foundation for Innovative New Diagnostics | CH | NGO, global PRND Dx dev. & impl. | |
| Carla Deakin | NICE | UK | Governmental, Dx assessment | |
| Eiichi Tamiya | Osaka University | JP | Dx Innovator | |
| Francis Moussy | World Health Organization, Observer | CH | IGO, global AMR Dx implementation | |
| Franck Molina | European Diagnostics Cluster Alliance | FR | Dx Industry Network | |
| Frank Apostel | R-Biopharm | DE | Dx Industry | |
| Frank Bier | Fraunhofer IZI | DE | Dx Innovator, research organisation | |
| Gerd Luedke | Curetis GmbH | DE | Dx Industry | |
| Guido Werner | Robert Koch Institute | DE | Federal Public Health Institute | |
| Gunnar Simonsen | University of Tromsø | NO | Health | |
| Gyorgy Abel | Lahey Hospital, Harvard University | US | Health | |
| Herman Goossens | Antwerp University | BE | Health, Policy | |
| Jacob Moran-Gilad | Ben-Gurion University & Ministry of Health | IL | Policy, Health, Dx Innovator | |
| James Fraser | Chipcare | CA | Dx Industry | |
| Jean-François de Lavison | Ahimsa Fund | FR | Non-profit Organization | |
| John Hays | Erasmus University Medical Center | NL | Dx Innovator, academic/medical | |
| John Rex | AstraZeneca | US | Pharma Industry | |
| Jordi Vila | University of Barcelona | ES | Health | |
| Karsten Becker | University Hospital Münster, DGHM | DE | Health | |
| Kate Templeton | NHS Lothian | UK | Health, Clinical Scientist | |
| Kirsten Miller-Duys | Hyrax Biosciences | SA | Dx Industry | |
| Konstantinos Mitsakakis | Hahn-Schickard, University of Freiburg | DE | Dx Innovator, research organisation | |
| Manica Balasegeram | GARD/DNDI | CH | NGO, drug development | |
| Mark Woolhouse | University of Edinburgh | UK | Infectious Disease Epidemiology | |
| Neil Butler | Spectromics | UK | Dx Industry | |
| Neil Woodford | Public Health England | UK | Health, Policy | |
| Paul Savelkoul | Maastricht University | NL | Health | |
| Petra Gastmeier | Charite Belin, Infect Control 2020 | DE | Health, Policy | |
| Philippe Lagace Wiens | University of Manitoba | CA | Health | |
| Ramanan Laxminarayan | Center for Disease Dynamics, Economics & Policy | US/IN | NGO, Public Health | |
| Rosanna Peeling | London School of Hygiene &Tropical Medicine | UK | Dx Innovator, academic/global health | |
| Saturnino Luz | Usher Institute | UK | Data Science | |
| Soeren Schubert | Max von Pettenkofer Institute Munich | DE | Health | |
| Stephan Harbarth | University of Geneva | CH | Health | |
| Sue Hill | NHS England | UK | Health, Policy | |
| Tracy Merlin | University of Adelaide | AU | Health Technology Assessment | |
| Taslimarif Saiyed | Centre for Cellular and Molecular Platforms | IN | Dx Innovator | |
| Thomas Wichelhaus | University Frankfurt; Paul Ehrlich Society | DE | Health | |
| Tjeerd van Staa | Farr Institute Health Informatics Research | UK | Data Science | |
| Valentina Di Gregori | University of Bologna | IT | Infectious Disease Epidemiology | |
| Wouter van der Wijngaart | KTH Royal Institute of Technology | SE | Micro- and nanosystems | |
| Wilfried von Eiff | HHL Leipzig | DE | Health economics | |